1. Home
  2. CYTK vs LRN Comparison

CYTK vs LRN Comparison

Compare CYTK & LRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • LRN
  • Stock Information
  • Founded
  • CYTK 1997
  • LRN 2000
  • Country
  • CYTK United States
  • LRN United States
  • Employees
  • CYTK N/A
  • LRN N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • LRN Other Consumer Services
  • Sector
  • CYTK Health Care
  • LRN Real Estate
  • Exchange
  • CYTK Nasdaq
  • LRN Nasdaq
  • Market Cap
  • CYTK 5.7B
  • LRN 4.7B
  • IPO Year
  • CYTK 2004
  • LRN 2007
  • Fundamental
  • Price
  • CYTK $45.82
  • LRN $116.57
  • Analyst Decision
  • CYTK Buy
  • LRN Buy
  • Analyst Count
  • CYTK 15
  • LRN 5
  • Target Price
  • CYTK $83.64
  • LRN $104.20
  • AVG Volume (30 Days)
  • CYTK 1.1M
  • LRN 713.9K
  • Earning Date
  • CYTK 02-25-2025
  • LRN 01-28-2025
  • Dividend Yield
  • CYTK N/A
  • LRN N/A
  • EPS Growth
  • CYTK N/A
  • LRN 53.12
  • EPS
  • CYTK N/A
  • LRN 5.50
  • Revenue
  • CYTK $3,219,000.00
  • LRN $2,110,972,000.00
  • Revenue This Year
  • CYTK N/A
  • LRN $13.18
  • Revenue Next Year
  • CYTK $710.83
  • LRN $8.32
  • P/E Ratio
  • CYTK N/A
  • LRN $21.18
  • Revenue Growth
  • CYTK N/A
  • LRN 11.55
  • 52 Week Low
  • CYTK $44.49
  • LRN $54.81
  • 52 Week High
  • CYTK $84.92
  • LRN $117.63
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 39.27
  • LRN 73.89
  • Support Level
  • CYTK $44.49
  • LRN $105.35
  • Resistance Level
  • CYTK $48.45
  • LRN $115.42
  • Average True Range (ATR)
  • CYTK 1.65
  • LRN 3.57
  • MACD
  • CYTK -0.08
  • LRN 0.72
  • Stochastic Oscillator
  • CYTK 23.50
  • LRN 92.37

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About LRN Stride Inc.

Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional, and Private Pay Schools and Other.

Share on Social Networks: